RK

Rajnish Kumar

Active Director Director DIN 08280877
DIN 08280877 First appointment Dec 2018 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2018
Shareholding value •••• Premium profile

About Rajnish Kumar

Data last updated:

Rajnish Kumar is a Director at Therapevo Pharmaceuticals Private Limited (since 2018). The company operates in Chemicals. Therapevo Pharmaceuticals Private Limited reported revenue of ₹8.5 Lakh (FY 2022).

DIN 08280877
Primary Designation Director
Industry Chemicals
First Appointment 03 Dec 2018
Oldest Company Age 7 yrs
Largest company Therapevo Pharmaceuticals Private Limited · ₹8.5 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Dec 20182018₹8.5 Lakh (FY 2022)Active

Board colleagues of Rajnish Kumar

Directorship timeline

Open interactive timeline →
Therapevo Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rajnish Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajnish Kumar

Rajnish Kumar currently holds 1 directorship: Therapevo Pharmaceuticals Private Limited (Director, since 03 Dec 2018, revenue ₹8.5 Lakh (FY 2022)).

Rajnish Kumar was first appointed on 03 Dec 2018 as Director at Therapevo Pharmaceuticals Private Limited.

The current boards of Rajnish Kumar's companies include Dipa (Therapevo Pharmaceuticals Private Limited), Jaya Singh (Therapevo Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available